David SATIJN

Person

Utrecht, NL

People

Patents Grantslast 30 patents

Information Patent Grant
Multispecific antibodies against CD40 and CD137
- Patent number 12,077,596
- Issue date Sep 3, 2024
- GENMAB A/S
- Isil Altintas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies
- Patent number 11,970,544
- Issue date Apr 30, 2024
- GENMAB A/S
- David Satijn
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Multispecific antibodies against CD40 and CD137
- Patent number 11,939,388
- Issue date Mar 26, 2024
- GENMAB A/S
- Isil Altintas
- G01 - MEASURING TESTING
Information Patent Grant
Nucleic acid molecules encoding binding agents to CD40 and 4-1BB (C...
- Patent number 11,814,411
- Issue date Nov 14, 2023
- BIONTECH SE
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies binding to CD30 and CD3
- Patent number 11,814,437
- Issue date Nov 14, 2023
- GENMAB A/S
- David Satijn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Agents, uses and methods for the treatment of synucleinopathy
- Patent number 11,542,323
- Issue date Jan 3, 2023
- H. Lundbeck A/S
- Pekka Kallunki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Agents, uses and methods for the treatment of synucleinopathy
- Patent number 11,524,995
- Issue date Dec 13, 2022
- H. Lundbeck A/S
- Pekka Kallunki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Binding agents binding to PD-L1 and CD137 and use thereof
- Patent number 11,459,395
- Issue date Oct 4, 2022
- Genmab A/S
- Isil Altintas
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Multispecific antibodies against CD40 and CD137
- Patent number 11,440,966
- Issue date Sep 13, 2022
- GENMAB A/S
- Isil Altintas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Agents, uses and methods for the treatment of synucleinopathy
- Patent number 11,421,024
- Issue date Aug 23, 2022
- H. Lundbeck A/S
- Pekka Kallunki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies
- Patent number 11,261,254
- Issue date Mar 1, 2022
- GENMAB A/S
- Louise Koopman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies
- Patent number 11,130,819
- Issue date Sep 28, 2021
- GENMAB A/S
- David Satijn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of producing multispecific antibodies against CD40 and CD137
- Patent number 11,091,557
- Issue date Aug 17, 2021
- GENMAB A/S
- Isil Altintas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibodies against HER2
- Patent number 11,091,553
- Issue date Aug 17, 2021
- GENMAB A/S
- Bart De Goeij
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multispecific antibodies against CD40 and CD137
- Patent number 11,084,882
- Issue date Aug 10, 2021
- Genmab A/S
- Isil Altintas
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibodies against HER2
- Patent number 11,046,771
- Issue date Jun 29, 2021
- GENMAB A/S
- Bart De Goeij
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies
- Patent number 11,008,399
- Issue date May 18, 2021
- GENMAB A/S
- David Satijn
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Binding agents binding to PD-L1 and CD137 and use thereof
- Patent number 10,968,280
- Issue date Apr 6, 2021
- GENMAB A/S
- Isil Altintas
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Agonistic tumor necrosis factor (TNF) receptor binding agents
- Patent number 10,927,181
- Issue date Feb 23, 2021
- BIONTECH SE
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Agents, uses and methods for the treatment of synucleinopathy
- Patent number 10,800,836
- Issue date Oct 13, 2020
- H. Lundbeck A/S
- Pekka Kallunki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Monoclonal antibodies against HER2 epitope
- Patent number 10,793,640
- Issue date Oct 6, 2020
- GENMAB A/S
- Bart De Goeij
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies binding AXL
- Patent number 10,765,743
- Issue date Sep 8, 2020
- GENMAB A/S
- Esther Breij
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Agents, uses and methods for the treatment of synucleinopathy
- Patent number 10,647,763
- Issue date May 12, 2020
- H. Lundbeck A/S
- Pekka Kallunki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Agents, uses and methods for the treatment of synucleinopathy
- Patent number 10,647,764
- Issue date May 12, 2020
- H. Lundbeck A/S
- Pekka Kallunki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Agents, uses and methods for the treatment of synucleinopathy
- Patent number 10,640,554
- Issue date May 5, 2020
- H. Lundbeck A/S
- Pekka Kallunki
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bispecific antibodies against CD3 and CD20
- Patent number 10,544,220
- Issue date Jan 28, 2020
- GENMAB A/S
- Patrick Engelberts
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies binding AXL
- Patent number 10,512,688
- Issue date Dec 24, 2019
- GENMAB A/S
- Esther Breij
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies binding AXL
- Patent number 10,500,276
- Issue date Dec 10, 2019
- GENMAB A/S
- Esther Breij
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of inducing T cell activation by administering an antibody...
- Patent number 10,457,735
- Issue date Oct 29, 2019
- BIONTECH SE
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies for the treatment of synucleinopathy
- Patent number 10,364,285
- Issue date Jul 30, 2019
- H. Lundbeck A/S
- Pekka Kallunki
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODIES CAPABLE OF BINDING TO OX40, VARIANTS THEREOF AND USES TH...
- Publication number 20240376221
- Publication date Nov 14, 2024
- GENMAB A/S
- Kristel Kemper
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VARIANTS OF CD38 ANTIBODY AND USES THEREOF
- Publication number 20240317881
- Publication date Sep 26, 2024
- GENMAB A/S
- Bart DE GOEIJ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST PD-L1
- Publication number 20240317861
- Publication date Sep 26, 2024
- GENMAB A/S
- Isil ALTINTAS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR
- Publication number 20240294661
- Publication date Sep 5, 2024
- GENMAB A/S
- David SATIJN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AGONISTIC TNF RECEPTOR BINDING AGENTS
- Publication number 20240254249
- Publication date Aug 1, 2024
- BIONTECH SE
- Ugur Sahin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TROGOCYTOSIS-MEDIATED THERAPY USING CD38 ANTIBODIES
- Publication number 20240254252
- Publication date Aug 1, 2024
- GENMAB A/S
- Bart E. C. G. DE GOEIJ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES BINDING TO CD30 AND CD3
- Publication number 20240228641
- Publication date Jul 11, 2024
- GENMAB A/S
- David SATIJN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES BINDING TO CD30 AND CD3
- Publication number 20240132607
- Publication date Apr 25, 2024
- GENMAB A/S
- David SATIJN
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES BINDING AXL
- Publication number 20240091352
- Publication date Mar 21, 2024
- GENMAB A/S
- Esther BREIJ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN ANTIBODIES AGAINST TISSUE FACTOR AND METHODS OF USE THEREOF
- Publication number 20230416403
- Publication date Dec 28, 2023
- GENMAB A/S
- Sandra VERPLOEGEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES CAPABLE OF BINDING TO ROR2 AND BISPECIFIC ANTIBODIES BIN...
- Publication number 20230365714
- Publication date Nov 16, 2023
- Louise Koopman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT
- Publication number 20230321261
- Publication date Oct 12, 2023
- GENMAB A/S
- Julia BOSHUIZEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Agents, Uses and Methods for the Treatment of Synucleinopathy
- Publication number 20230312693
- Publication date Oct 5, 2023
- H. LUNDBECK A/S
- Pekka KALLUNKI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BINDING AGENTS BINDING TO EPCAM AND CD137
- Publication number 20230295335
- Publication date Sep 21, 2023
- GENMAB A/S
- Andreea IOAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BISPECIFIC ANTIBODIES BINDING TO 5T4 AND CD3 FOR USE IN TREATMENT O...
- Publication number 20230257479
- Publication date Aug 17, 2023
- GENMAB A/S
- David SATIJN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES TH...
- Publication number 20230212301
- Publication date Jul 6, 2023
- GENMAB B.V.
- Andreea Ioan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES BINDING TO CD30 AND CD3
- Publication number 20230132049
- Publication date Apr 27, 2023
- GENMAB A/S
- David SATIJN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES TH...
- Publication number 20230109496
- Publication date Apr 6, 2023
- GENMAB B.V.
- Andreea Ioan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BINDING AGENTS BINDING TO PD-L1 AND CD137 AND USE THEREOF
- Publication number 20230087745
- Publication date Mar 23, 2023
- GENMAB A/S
- Isil ALTINTAS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137
- Publication number 20230089969
- Publication date Mar 23, 2023
- GENMAB A/S
- Isil ALTINTAS
- G01 - MEASURING TESTING
Information Patent Application
MULTISPECIFIC ANTIGEN-BINDING MOLECULE WITH IMPROVED INTERNALIZATIO...
- Publication number 20230076417
- Publication date Mar 9, 2023
- GENMAB A/S
- Bart DE GOEIJ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-DEATH RECEPTOR ANTIBODIES AND METHODS OF USE THEREOF
- Publication number 20220411522
- Publication date Dec 29, 2022
- GENMAB B.V.
- Frank BEURSKENS
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES
- Publication number 20220324980
- Publication date Oct 13, 2022
- GENMAB A/S
- Louise KOOPMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MONOCLONAL ANTIBODIES AGAINST HER2
- Publication number 20220169738
- Publication date Jun 2, 2022
- GENMAB A/S
- Bart DE GOEIJ
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137
- Publication number 20220064317
- Publication date Mar 3, 2022
- GENMAB A/S
- Isil ALTINTAS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES
- Publication number 20220048999
- Publication date Feb 17, 2022
- GENMAB A/S
- Louise KOOPMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES
- Publication number 20220049013
- Publication date Feb 17, 2022
- GENMAB A/S
- David SATIJN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137
- Publication number 20220033510
- Publication date Feb 3, 2022
- GENMAB A/S
- Isil ALTINTAS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY FORMULATION
- Publication number 20210369842
- Publication date Dec 2, 2021
- GENMAB A/S
- Isil ALTINTAS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137
- Publication number 20210317225
- Publication date Oct 14, 2021
- GENMAB A/S
- Isil ALTINTAS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

David SATIJN

Person

Patents Grantslast 30 patents

Multispecific antibodies against CD40 and CD137

Antibodies

Multispecific antibodies against CD40 and CD137

Nucleic acid molecules encoding binding agents to CD40 and 4-1BB (C...

Antibodies binding to CD30 and CD3

Agents, uses and methods for the treatment of synucleinopathy

Agents, uses and methods for the treatment of synucleinopathy

Binding agents binding to PD-L1 and CD137 and use thereof

Multispecific antibodies against CD40 and CD137

Agents, uses and methods for the treatment of synucleinopathy

Antibodies

Antibodies

Methods of producing multispecific antibodies against CD40 and CD137

Monoclonal antibodies against HER2

Multispecific antibodies against CD40 and CD137

Monoclonal antibodies against HER2

Antibodies

Binding agents binding to PD-L1 and CD137 and use thereof

Agonistic tumor necrosis factor (TNF) receptor binding agents

Agents, uses and methods for the treatment of synucleinopathy

Monoclonal antibodies against HER2 epitope

Antibodies binding AXL

Agents, uses and methods for the treatment of synucleinopathy

Agents, uses and methods for the treatment of synucleinopathy

Agents, uses and methods for the treatment of synucleinopathy

Bispecific antibodies against CD3 and CD20

Antibodies binding AXL

Antibodies binding AXL

Methods of inducing T cell activation by administering an antibody...

Antibodies for the treatment of synucleinopathy

Patents Applicationslast 30 patents

ANTIBODIES CAPABLE OF BINDING TO OX40, VARIANTS THEREOF AND USES TH...

VARIANTS OF CD38 ANTIBODY AND USES THEREOF

ANTIBODIES AGAINST PD-L1

HUMAN ANTIBODY DRUG CONJUGATES AGAINST TISSUE FACTOR

AGONISTIC TNF RECEPTOR BINDING AGENTS

TROGOCYTOSIS-MEDIATED THERAPY USING CD38 ANTIBODIES

ANTIBODIES BINDING TO CD30 AND CD3

ANTIBODIES BINDING TO CD30 AND CD3

ANTIBODIES BINDING AXL

HUMAN ANTIBODIES AGAINST TISSUE FACTOR AND METHODS OF USE THEREOF

ANTIBODIES CAPABLE OF BINDING TO ROR2 AND BISPECIFIC ANTIBODIES BIN...

AXL-SPECIFIC ANTIBODY-DRUG CONJUGATES FOR CANCER TREATMENT

Agents, Uses and Methods for the Treatment of Synucleinopathy

BINDING AGENTS BINDING TO EPCAM AND CD137

BISPECIFIC ANTIBODIES BINDING TO 5T4 AND CD3 FOR USE IN TREATMENT O...

ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES TH...

ANTIBODIES BINDING TO CD30 AND CD3

ANTIBODIES CAPABLE OF BINDING TO CD27, VARIANTS THEREOF AND USES TH...

BINDING AGENTS BINDING TO PD-L1 AND CD137 AND USE THEREOF

MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137

MULTISPECIFIC ANTIGEN-BINDING MOLECULE WITH IMPROVED INTERNALIZATIO...

ANTI-DEATH RECEPTOR ANTIBODIES AND METHODS OF USE THEREOF

ANTIBODIES

MONOCLONAL ANTIBODIES AGAINST HER2

MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137

ANTIBODIES

ANTIBODIES

MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137

ANTIBODY FORMULATION

MULTISPECIFIC ANTIBODIES AGAINST CD40 AND CD137